Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-03

Clinical Trial Update: Nefopam Versus Ondansteron for Prevention of Post Spinal Shivering. [Phase 4]

View source ↗

Summary

Clinical trial comparing nefopam to ondansetron for prevention of post-spinal shivering in a Phase 4 study; status and detailed results are not provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nefopam (nefopam)
  • Ondansetron (ondansetron)

Snippet

Sponsor: Saint-Joseph University | Conditions: Shivering, Adverse Effects in the Therapeutic Use of Anaesthetic | Phase 4 | Status: UNKNOWN